No abstract available
Keywords:
GLP-1 analogue; antiobesity drug; clinical trial; obesity therapy; phase III study; weight control.
Publication types
-
Clinical Trial, Phase III
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucagon-Like Peptides / therapeutic use
-
Humans
-
Hypoglycemic Agents
-
Obesity / complications
-
Obesity / drug therapy
-
Overweight* / complications
-
Overweight* / drug therapy
Substances
-
Hypoglycemic Agents
-
semaglutide
-
Glucagon-Like Peptides
Associated data
-
ClinicalTrials.gov/NCT04074161